Navigation Links
inVentiv Health Provides Updated Information on December 11th Investor Day
Date:12/3/2007

SOMERSET, N.J., Dec. 3 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. (Nasdaq: VTIV) today provided updated information on its upcoming Investor Day, which will be held Tuesday, December 11th, 2007 in New York City. The event will be begin at 8:30 a.m., not 9:00 a.m. as announced earlier, and will conclude at noon, followed by lunch.

The agenda will include a business overview, presentations by the leaders of each of the four major divisions, and a look at inVentiv's growing focus on integrated services.

The event will be held at the offices of inVentiv's Chandler Chicco Agency (CCA) business unit, located at 450 West 15th Street, Suite #700 in New York City. Please go to http://selectsurvey.inventivcommunications.com/TakeSurvey.aspx?SurveyID=88K I95 6 to request an invitation. Those who do not have Internet access can call (732) 537-4804.

The meeting is open to analysts and investors and will be accessible by live audio webcast on inVentiv Health's website at http://www.inventivhealth.com/health/newsroom/webcasts.asp. Presentation slides also will be available for all participants and an archived version of the webcast will be available on inVentiv Health's website for one week following the presentation.

Webcast segments will include:

8:30 a.m. - 10:30 a.m. Overview and Divisional Presentations

11 a.m. - noon Integrated Opportunities, Summary and Discussion

To listen to the presentation live, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). A replay of the call will be available immediately following the call through December 18, 2007 at 800-642-1687 (Domestic) or 706-645-9291 (International). The conference ID number for the replay is 23949575.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 275 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.


'/>"/>
SOURCE inVentiv Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
2. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
3. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
4. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
5. inVentiv Health Creates Client Development and Integration Team
6. Penn study finds pro-death proteins required to regulate healthy immune function
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Air pollution linked to cardiovascular risk indices in healthy young adults
9. More proof needed of safety and quality of electronic personal health records
10. Health care incentive model offers collaborative approach
11. Loneliness is bad for your health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm Study, ... children aged 3-8 with Autism, is now enrolling at three new sites. These new ... United States. , “There are currently no approved drugs that address the core ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has lived ... continued to spiritually evolve, which is the purpose of everyone in this universe. As ... ” (published by Balboa Press) attempts to guide readers to expand one’s spiritual life. ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Gevir, a ... deer antler velvet, announced its products are coming soon to Amazon.com, the world’s largest ... Shelley Thomson as a means to develop an effective natural treatment for Shelley’s Multiple ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... secure messaging services to the largest network of hospitals, health information exchanges, ... National Coordinator for Health Information Technology (ONC-HIT) 2015 Edition Health IT Module Certification ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... approach, leads to fewer trips the emergency room, fewer hospital admissions, and better ... Journal of Managed Care® (AJMC®) finds. The study can be found here ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , Feb. ... OGXI ) today announced its year end 2016 financial ... In January 2017, OncoGenex, and Achieve Life Science, Inc., a ... entered into a definitive merger agreement under which OncoGenex ... of the proposed merger, Achieve,s stockholders are expected to ...
Breaking Medicine Technology: